Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34807814 | chr2:239104639 | T/TG | 0.000113 | 170 | 33.32 | 20.13 | 19.87 | KM Plot |
PCPG | rs34810851 | chr14:74341128 | C/G | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs34820661 | chr2:107213578 | CT/C | 0.000256 | 174 | 26.57 | 23.53 | 25.92 | KM Plot |
PCPG | rs34826545 | chr17:50299063 | A/G | 6.24E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs34846031 | chr16:1770201 | G/A | 2.12E-11 | 172 | 25.67 | 18.2 | 4.52 | KM Plot |
PCPG | rs34849731 | chr16:71578927 | G/A | 0.000145 | 174 | 25.17 | 29.57 | 15.82 | KM Plot |
PCPG | rs34850152 | chr16:90058161 | T/TG | 1.09E-8 | 172 | 25.77 | 20.28 | 6.62 | KM Plot |
PCPG | rs34851373 | chr15:31101436 | G/A | 1.11E-16 | 172 | 25.92 | 23.83 | 2.12 | KM Plot |
PCPG | rs34856800 | chr3:150895382 | T/C | 0.000407 | 171 | 24.85 | 29.43 | 60.03 | KM Plot |
PCPG | rs34859361 | chr14:74341604 | C/T | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs34872575 | chr3:52986277 | G/A | 6.56E-6 | 176 | 25.17 | 26.57 | 11.78 | KM Plot |
PCPG | rs34887893 | chr17:50302857 | C/T | 3.24E-5 | 178 | 26.57 | 27.2 | 14.43 | KM Plot |
PCPG | rs34888109 | chr13:37543553 | AT/A | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs34889414 | chr17:50276929 | C/G | 6.66E-5 | 177 | 25.77 | 27.95 | 14.47 | KM Plot |
PCPG | rs34902125 | chr16:71477413 | CA/C | 0.000119 | 177 | 24.5 | 27.22 | 43.12 | KM Plot |